Rocket Pharmaceuticals Inc buy BiotechBee
Start price
08.06.24
/
50%
€20.70
Target price
31.01.26
€32.00
Performance (%)
-44.44%
End price
14.12.24
€11.50
Summary
This prediction ended on 14.12.24 with a price of €11.50. The BUY prediction by BiotechBee for Rocket Pharmaceuticals Inc performed very badly with a performance of -44.44%. BiotechBee has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Rocket Pharmaceuticals Inc | -0.523% | -0.523% | 35.591% |
| iShares Core DAX® | 0.734% | -0.964% | 17.910% |
| iShares Nasdaq 100 | -2.686% | -2.409% | 4.267% |
| iShares Nikkei 225® | -2.261% | -4.038% | 10.420% |
| iShares S&P 500 | -1.346% | -1.510% | 1.615% |
According to BiotechBee what are the pros and cons of Rocket Pharmaceuticals Inc for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Rocket Pharmaceuticals Inc diskutieren
Buy mit Kursziel 32,0
In the thread Trading Rocket Pharmaceuticals Inc
Stopped prediction by BiotechBee for Rocket Pharmaceuticals Inc
Rocket Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€17.96
26.10.22
26.10.22
€28.00
31.12.24
31.12.24
15.29%
08.06.24
08.06.24
Could be very worthwhile Investment >20% year
